Phreesia Q3 revenue $73.1M (+31% YoY); raises FY2023 outlook to at least $278M

Phreesia, Inc.

2023-Q3 EPS reported -$2.64 revenue$204,324,000

Revenue $73.1M (+31% YoY); net loss $40.2M; Adjusted EBITDA -$18.3M.
Average healthcare services clients 2,982 (+42% YoY); ARPU $17,645 (-9% YoY).
Raises FY2023 revenue outlook to at least $278M; Adjusted EBITDA outlook improved to ~$95M.
Renames 'Life sciences' revenue to 'Network solutions'; introduces MemberConnect for payers.
Estimated TAM expanded to ~$10B from ~$9B due to MemberConnect opportunity.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Phreesia, Inc. reported the fiscal quarter ended October 31, 2022 results: revenue $73.1 million, net income $40.2 million. Guidance raised.

Period: the fiscal quarter ended October 31, 2022
Revenue: $73.1 million
Net income: $40.2 million
Guidance: raised
Result: reported results

Exact text from the filing

Revenue was $73.1 million in the quarter as compared to $55.9 million in the same period in the prior year, an increase of 31%.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

Phreesia, Inc. filing history →

Source: SEC EDGAR

accession 0001412408-22-000066

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.